The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 2×
“Now, AD affects approximately 15 million people worldwide, and the number of affected individuals in the U.S. and Europe is expected to triple by the year 2050 (Hebert et al., 2003), underscoring the need for effective treatments or preventive interventions.”
BackgroundHydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074 · cited 1×
“Themolecular mechanism of Aβ-induced cytotoxicity has not been fully explored; however this toxicity does involve formation of oxygen radicals (Behl et al., 1994; Harris et al., 1995; Malyshev et al., 2005), nitric oxide (Malyshev et al., 2005; Sutton et al., 1997), and disruption of calcium…”
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 5×
“Although Aβ is targeted as one of the primary causes of AD, Aβ is constitutively secreted by mammalian cells and normally occurs in plasma and cerebrospinal fluid (CSF) (Haass et al., 1992; Shoji et al., 1992).”
BackgroundInfluentialSearching for genetic determinants in the new millennium
Risch, N. J. (2000) · Nature · doi:10.1038/35015718 · Cited by 1,839
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818 · cited 1×
“Early studies on presenilins yielded different conclusions with some finding that presenilin is a co-factor for γ-secretase (De Strooper et al., 1998), and others that presenilin is itself a γ-secretase (Wolfe et al., 1999).”
ResultProduction of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447 · cited 4×
“Although Aβ is targeted as one of the primary causes of AD, Aβ is constitutively secreted by mammalian cells and normally occurs in plasma and cerebrospinal fluid (CSF) (Haass et al., 1992; Shoji et al., 1992).”
BackgroundInfluentialA68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 1×
“The first neuropathological case was first described over 100 years ago by the presence of senile plaques and neurofibrillary tangles in the brain (Alzheimer, 1907, Lee et al., 1991).”
BackgroundManczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
Cited by
Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease
TCW, J., & Goate, A. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024539 · Cited by 242
Armato, U., Chiarini, A., Chakravarthy, B., Chioffi, F., Pacchiana, R., Colarusso, E., Whitfield, J. F., & Dal Prà, I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.020 · Cited by 68
Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease
Chiarini, A., Armato, U., Liu, D., & Dal Prà, I. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00134 · Cited by 51
An isoform‐specific role of FynT tyrosine kinase in Alzheimer's disease
Lee, C., Low, C. Y. B., Francis, P. T., Attems, J., Wong, P. T. ‐., Lai, M. K. P., & Tan, M. G. K. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13429 · Cited by 27
Itokazu, Y., & Yu, R. K. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8634-8 · Cited by 27
Metadata
- Authors
- Kaminsky, Y. G., Marlatt, M. W., Smith, M. A., & Kosenko, E. A.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 221
- Issue
- 1
- Pages
- 26-37
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2093395322
- Cited by
- 165
- References
- 30
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35. https://app.cochat.ai/papers/10.1016/j.expneurol.2009.09.005
- The paper
- Kaminsky, Y. G., Marlatt, M. W., Smith, M. A., & Kosenko, E. A. (2010). Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2009.09.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.